BE899000A - DILTIAZEM COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF ARTERIOSCLEROSIS - Google Patents

DILTIAZEM COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF ARTERIOSCLEROSIS

Info

Publication number
BE899000A
BE899000A BE0/212448A BE212448A BE899000A BE 899000 A BE899000 A BE 899000A BE 0/212448 A BE0/212448 A BE 0/212448A BE 212448 A BE212448 A BE 212448A BE 899000 A BE899000 A BE 899000A
Authority
BE
Belgium
Prior art keywords
arteriosclerosis
prophylaxis
treatment
diltiazem
compositions
Prior art date
Application number
BE0/212448A
Other languages
French (fr)
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of BE899000A publication Critical patent/BE899000A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

L'invention concerne une composition pharmaceutique destinée à la prophylaxie et au traitement de l'artériosclérose, comme l'athérosclérose, la sclérose de Monkeberg et l'artériolosclérose, caractérisée en ce qu'elle comprend, à titre d'ingrédient actif, du diltiazem ou un sel d'addition d'un acide pharmaceutiquement acceptable de ce composé, ainsi qu'un procédé de prophylaxie et de traitement de l'artériosclérose précitée par l'administration du diltiazem ou d'un sel de ce composé à un patient.The invention relates to a pharmaceutical composition intended for the prophylaxis and treatment of arteriosclerosis, such as atherosclerosis, Monkeberg sclerosis and arteriolosclerosis, characterized in that it comprises, as active ingredient, diltiazem or a pharmaceutically acceptable acid addition salt of this compound, as well as a method of prophylaxis and treatment of the above arteriosclerosis by administering diltiazem or a salt of this compound to a patient.

BE0/212448A 1983-02-25 1984-02-24 DILTIAZEM COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF ARTERIOSCLEROSIS BE899000A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58031515A JPS59157021A (en) 1983-02-25 1983-02-25 Preventive and remedy agent for arteriosclerosis

Publications (1)

Publication Number Publication Date
BE899000A true BE899000A (en) 1984-06-18

Family

ID=12333337

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212448A BE899000A (en) 1983-02-25 1984-02-24 DILTIAZEM COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF ARTERIOSCLEROSIS

Country Status (12)

Country Link
JP (1) JPS59157021A (en)
BE (1) BE899000A (en)
CH (1) CH658389A5 (en)
DE (1) DE3406837A1 (en)
DK (1) DK163712C (en)
FR (1) FR2541577B1 (en)
GB (1) GB2135192B (en)
HK (1) HK45389A (en)
IT (1) IT1178863B (en)
NL (1) NL8400548A (en)
SE (1) SE8400971L (en)
SG (1) SG21189G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
JPS63107925A (en) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd Preventive and treating agent for arteriosclerosis
JP2658783B2 (en) * 1992-12-10 1997-09-30 田辺製薬株式会社 Anti-atherosclerotic agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
GB1236467A (en) * 1967-10-28 1971-06-23 Tanabe Seiyaku Co Benzothiazepine derivatives

Also Published As

Publication number Publication date
DE3406837C2 (en) 1990-12-20
SE8400971L (en) 1984-08-26
DE3406837A1 (en) 1984-08-30
GB8405060D0 (en) 1984-04-04
HK45389A (en) 1989-06-16
CH658389A5 (en) 1986-11-14
SE8400971D0 (en) 1984-02-22
JPS6358809B2 (en) 1988-11-17
DK163712B (en) 1992-03-30
DK103084A (en) 1984-08-26
NL8400548A (en) 1984-09-17
IT8467183A1 (en) 1985-08-24
SG21189G (en) 1990-01-26
JPS59157021A (en) 1984-09-06
DK163712C (en) 1992-08-31
IT8467183A0 (en) 1984-02-24
FR2541577A1 (en) 1984-08-31
DK103084D0 (en) 1984-02-24
IT1178863B (en) 1987-09-16
GB2135192A (en) 1984-08-30
FR2541577B1 (en) 1987-05-22
GB2135192B (en) 1986-10-22

Similar Documents

Publication Publication Date Title
AU6767587A (en) Pharmaceutical compositions
ES8603870A1 (en) Derivatives of 2,2'-iminobisethanol.
FR2356424A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON PHOPHONOFORMIC ACID USEFUL IN THE FIGHT AGAINST VIRAL INFECTIONS
BE901737A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE MYOCARDIAL ISCHEMIA.
FI935847A (en) L-DOPA ester compositions
CA2191129A1 (en) Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin
RU94046137A (en) Phosphonosulfonate compounds for treatment anomal calcium and phosphate metabolism, pharmaceutical composition
FI945599A0 (en) Phosphonocarboxylate compounds for the treatment of abnormal calcium and phosphate metabolism
BE900564A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES.
ES555118A0 (en) METHOD OF PREPARING MEDICINES INCLUDING A BONE SEARCH AGENT AND A CARBONIC ANHYDASE INHIBITOR, TO PREVENT AND CURE BONE DISEASES.
ES8504682A1 (en) New nitro aliphatic compounds, process for preparation thereof and use thereof.
BE1002239A5 (en) PHARMACEUTICAL SOLUTION.
FR2393577A1 (en) B- (P-HALOGENOPHENYL) -G-AMINOBUTYRIC ACID BASED MEDICINAL PRODUCT FOR THE TREATMENT OF ANXIETY NEPROSIS
BE899000A (en) DILTIAZEM COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF ARTERIOSCLEROSIS
CA2136825A1 (en) Quaternary Nitrogen-Containing Phosphonate Compounds, for Treating Abnormal Calcium and Phosphate Metabolism as Well as Dental Calculus and Plaque
MA24670A1 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-PHENYL-4-CYANO-CYCLOHEXANOIC ACIDS
MA26744A1 (en) POLYMORPHS OF A CRYSTALLINE AZO-BICYCLO-2,2,2-OCT-3-YLAMINE CHLORHYDRATE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA27157A1 (en) METHOD FOR THE TREATMENT OF BONE CONDITIONS.
CA2136823A1 (en) Phosphonosulfonate Compounds for Treating Abnormal Calcium and Phosphate Metabolism
FR2433943A1 (en) DRUG PREPARATIONS ESPECIALLY FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
BE901879A (en) ANALOGUE PRODUCTS OF 1ALPHA-HYDROXYVITAMIN D2, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US4663345A (en) Etodolac for treatment of gout
ATE275953T1 (en) 2,3 DIARYL-1-BENZOPYRAMES FOR THE TREATMENT OF DERMATITIS
RU94046103A (en) Quaternary nitrogen-containing phosphonate compounds for treatment of anomal calcium and phosphate metabolism, pharmaceutical composition, method of treatment
BE1002060A3 (en) THERAPEUTIC AGENT AND ITS USE.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: TANABE SEIYAKU CO. LTD

Effective date: 19990228